The Journal of Nutritional Biochemistry
Volume 18, Issue 12 , Pages 785-794 , December 2007

Effect of almond skin polyphenolics and quercetin on human LDL and apolipoprotein B-100 oxidation and conformation

Received 12 June 2006 ,Revised 19 September 2006 ,Accepted 8 December 2006.

References 

  1. Jenkins DJ, Kendall CW, Marchie A, Parker TL, Connelly PW, Qian W, et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation. 2002;106:1327–1332
  2. Lovejoy JC, Most MM, Lefevre M, Greenway FL, Rood JC. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr. 2002;76:1000–1006
  3. Jaceldo-Siegl K, Sabate J, Rajaram S, Fraser GE. Long-term almond supplementation without advice on food replacement induces favourable nutrient modifications to the habitual diets of free-living individuals. Br J Nutr. 2004;92:533–540
  4. Ellsworth JL, Kushi LH, Folsom AR. Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women's Health Study. Nutr Metab Cardiovasc Dis. 2001;11:372–377
  5. Sabate J. Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am J Clin Nutr. 1999;70:500S–503S
  6. Hu FB, Stampfer MJ. Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence. Curr Atheroscler Rep. 1999;1:204–209
  7. Frison-Norrie S, Sporns P. Identification and quantification of flavonol glycosides in almond seedcoats using MALDI-TOF MS. J Agric Food Chem. 2002;50:2782–2787
  8. Sang S, Lapsley K, Jeong W-S, LaChance PA, Ho C-T, Rosen RT. Antioxidative phenolic compounds isolated from almond skins (Prunus amygdalus Batsch). J Agric Food Chem. 2002;50:2459–2463
  9. Wijeratne SS, Abou-Zaid MM, Shahidi F. Antioxidant polyphenols in almond and its coproducts. J Agric Food Chem. 2006;54:312–318
  10. Milbury PE, Chen CY, Dolnikowski GG, Blumberg JB. Determination of flavonoids and phenolics and their distribution in almonds. J Agric Food Chem. 2006;[ASAP Web release date: 02-Jun-2006; (article) DOI: 10.1021/jf0603937]
  11. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001;74:418–425
  12. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915–924
  13. Abuja PM, Lohner K, Prassl R. Modification of the lipid–protein interaction in human low-density lipoprotein destabilizes ApoB-100 and decreases oxidizability. Biochemistry. 1999;38:3401–3408
  14. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998;39:1529–1542
  15. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic Res Commun. 1989;6:67–75
  16. Giessauf A, Steiner E, Esterbauer H. Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-independent process during copper-mediated oxidation of LDL. Biochim Biophys Acta. 1995;1256:221–232
  17. Giessauf A, van Wickern B, Simat T, Steinhart H, Esterbauer H. Formation of N-formylkynurenine suggests the involvement of apolipoprotein B-100 centered tryptophan radicals in the initiation of LDL lipid peroxidation. FEBS Lett. 1996;389:136–140
  18. Batthyany C, Santos CX, Botti H, Cervenansky C, Radi R, Augusto O, et al. Direct evidence for apo B-100-mediated copper reduction: studies with purified apo B-100 and detection of tryptophanyl radicals. Arch Biochem Biophys. 2000;384:335–340
  19. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341–390
  20. Keri L. Production of oxidized lipids during modification of LDL by macrophages or copper. J Biochem. 1994;304:625–633
  21. Vedie B, Myara I, Pech MA, Maziere JC, Maziere C, Caprani A, et al. Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography. J Lipid Res. 1991;32:1359–1369
  22. Sevanian A, Bittolo-Bon G, Cazzolato G, Hodis H, Hwang J, Zamburlini A, et al. LDL− is a lipid hydroperoxide-enriched circulating lipoprotein. J Lipid Res. 1997;38:419–428
  23. Sanchez-Quesada JL, Otal-Entraigas C, Franco M, Jorba O, Gonzalez-Sastre F, Blanco-Vaca F, et al. Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 1999;84:655–659
  24. Sanchez-Quesada JL, Perez A, Caixas A, Rigla M, Payes A, Benitez S, et al. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. J Clin Endocrinol Metab. 2001;86:3243–3249
  25. Tanigawa H, Miura SI, Zhang B, Uehara Y, Matsuo Y, Fujino M, et al. Low-density lipoprotein oxidized to various degrees activates ERK1/2 through Lox-1. Atherosclerosis. 2005;[electronic publication ahead of print], doi:10.1016/j.atherosclerosis.2005.10.046
  26. Hazell LJ, Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. J Biochem. 1993;290:165–172
  27. Brunelli R, Mei G, Krasnowska EK, Pierucci F, Zichella L, Ursini F, et al. Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation. Biochemistry. 2000;39:13897–13903
  28. Knott HM, Baoutina A, Davies MJ, Dean RT. Comparative time-courses of copper-ion-mediated protein and lipid oxidation in low-density lipoprotein. Arch Biochem Biophys. 2002;400:223–232
  29. Barclay LR, Ingold KU. Autoxidation of biological molecules: 2. The autoxidation of a model membrane. A comparison of the autoxidation of egg lecithin phosphatidylcholine in water and in chlorobenzene. J Am Chem Soc. 1981;103:6478–6485
  30. Chen CY, Milbury PE, Lapsley K, Blumberg JB. Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. J Nutr. 2005;135:1366–1373
  31. Milde J, Elstner EF, Grassmann J. Synergistic inhibition of low-density lipoprotein oxidation by rutin, gamma-terpinene, and ascorbic acid. Phytomedicine. 2004;11:105–113
  32. Chen CY, Milbury PE, Kwak HK, Collins FW, Samuel P, Blumberg JB. Avenanthramides and phenolic acids from oats are bioavailable and act synergistically with vitamin C to enhance hamster and human LDL resistance to oxidation. J Nutr. 2004;134:1459–1466
  33. Hwang J, Sevanian A, Hodis HN, Ursini F. Synergistic inhibition of LDL oxidation by phytoestrogens and ascorbic acid. Free Radic Biol Med. 2000;29:79–89
  34. Filipe P, Lanca V, Silva JN, Morliere P, Santus R, Fernandes A. Flavonoids and urate antioxidant interplay in plasma oxidative stress. Mol Cell Biochem. 2001;221:79–87
  35. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, et al. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb. 1994;14:1892–1899
  36. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372–1376
  37. Salonen JT, Salonen R, Seppanen K, Kantola M, Suntioinen S, Korpela H. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. BMJ. 1991;302:756–760
  38. Dousset N, Taus M, Ferretti G, Dousset JC, Curatola G, Valdiguie P. Physico-chemical properties of copper-oxidized very low density lipoproteins. Biochem Mol Biol Int. 1998;45:1021–1030
  39. Mowry H-O, Okhuma S, Takano T. Monoclonal DLR1a/104G antibody recognising peroxidized lipoproteins in atherosclerotic lesions. Biochim Biophys Acta. 1988;963:208–214
  40. Patel RP, Darley-Usmar VM. Molecular mechanisms of the copper dependent oxidation of low-density lipoprotein. Free Rad Res. 1999;30:1–9
  41. Singleton VL, Orthofer R, Lamuela-Raventos RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 1999;299:152–178
  42. Ramos P, Gieseg SP, Schuster B, Esterbauer H. Effect of temperature on oxidation resistance of low-density lipoprotein. J Lipid Res. 1995;36:2113–2128
  43. Chung BH, Wilkinson T, Geer JC, Segrest JP. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res. 1980;21:284–291
  44. Parasassi T, De Stasio G, Ravagnan G, Rusch RM, Gratton E. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. J Biophys. 1991;60:179–189
  45. Dousset N, Ferretti G, Taus M, Valdiguie P, Curatola G. Fluorescence analysis of lipoprotein peroxidation. Methods Enzymol. 1994;233:459–469
  46. Ioku K, Tsushida T, Takei Y, Nakatani N, Terao J. Antioxidative activity of quercetin and quercetin monoglucosides in solution and phospholipid bilayers. Biochim Biophys Acta. 1995;1234:99–104
  47. Yamamoto N, Moon JH, Tsushida T, Nagao A, Terao J. Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Arch Biochem Biophys. 1999;372:347–354
  48. Yeomans VC, Linseisen J, Wolfram G. Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu(2+)-mediated oxidative modification of human low density lipoproteins. Eur J Nutr. 2005;44:422–428
  49. Cominacini L, Garbin U, Davoli A, Micciolo R, Bosello O, Gaviraghi G, et al. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res. 1991;32:349–358
  50. Filipe P, Morliere P, Patterson LK, Hug GL, Maziere JC, Maziere C, et al. Repair of amino acid radicals of apolipoprotein B100 of low-density lipoproteins by flavonoids. A pulse radiolysis study with quercetin and rutin. Biochemistry. 2002;41:11057–11064
  51. Miranda CL, Stevens JF, Ivanov V, McCall M, Frei B, Deinzer ML, et al. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem. 2000;48:3876–3884
  52. Ferretti G, Bacchetti T, Bicchiega V, Curatola G. Effect of human apo AIV against lipid peroxidation of very low density lipoproteins. Chem Phys Lipids. 2002;114:45–54
  53. Ferretti G, Bacchetti T, Menanno F, Curatola G. Effect of genistein against copper-induced lipid peroxidation of human high density lipoproteins (HDL). Atherosclerosis. 2004;172:55–61

☆ This work was supported by the U.S. Department of Agriculture (USDA) Agricultural Research Service under Cooperative Agreement No. 58-1950-4-401 and the Almond Board of California.

PII: S0955-2863(07)00025-3

doi: 10.1016/j.jnutbio.2006.12.015

The Journal of Nutritional Biochemistry
Volume 18, Issue 12 , Pages 785-794 , December 2007

Article Tools

* Image Usage & Resolution